TB HCPCS Level II modifier: Drug or biological acquired with 340b drug pricing program discount, reported for informational purposes

TB is a HCPCS Level II modifier: “Drug or biological acquired with 340b drug pricing program discount, reported for informational purposes.” It adds this detail to the code it is reported with.

Official description

TB

Drug or biological acquired with 340b drug pricing program discount, reported for informational purposes

Short description: 340b drug

HCPCS · United States

Medicare details

The indicators CMS publishes with TB in its October 2026 file. They describe Medicare’s handling, not another payer’s.

Medicare coverage
Carrier judgment
Added
Jan 1, 2018

Where TB sits

  1. 1GroupHCPCS modifiers
  2. 2Modifier TBDrug or biological acquired with 340b drug pricing program discount, reported for informational purposes

Source and release

Data release
HCPCS Level II · October 2026
Effective date
Oct 1, 2026
Publisher
CMS

This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.

Frequently asked questions

What does HCPCS code TB mean?

TB is the HCPCS code for “Drug or biological acquired with 340b drug pricing program discount, reported for informational purposes” in CMS’s HCPCS Level II October 2026 release.

Where is TB in the HCPCS Level II list?

TB is listed under Modifiers.

Does Medicare cover TB?

CMS lists TB’s Medicare coverage as “Carrier judgment”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.

Which HCPCS Level II release does this page use?

It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.